Should You Buy AbbVie Inc (ABBV) Stock on Monday?

The market has been neutral on AbbVie Inc (ABBV) stock recently. ABBV gets a Neutral score from InvestorsObserver Stock Sentiment Indicator.

AbbVie Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on ABBV!

See Full ABBV Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With ABBV Stock Today?

AbbVie Inc (ABBV) stock is trading at $110.69 as of 1:12 PM on Monday, Oct 11, a decline of -$0.49, or -0.44% from the previous closing price of $111.18. The stock has traded between $110.61 and $111.40 so far today. Volume today is less active than usual. So far 2,342,230 shares have traded compared to average volume of 8,938,478 shares. To screen for more stocks like AbbVie Inc click here.

More About AbbVie Inc

AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health. Click Here to get the full Stock Report for AbbVie Inc stock.